Literature DB >> 11491150

High-resolution computed tomography scanning in alpha1-antitrypsin deficiency: relationship to lung function and health status.

L J Dowson1, P J Guest, S L Hill, R L Holder, R A Stockley.   

Abstract

The development of computed tomography (CT) has enabled emphysema to be assessed noninvasively. Objective quantification of lung density correlates well with lung function in patients with chronic obstructive pulmonary disease and has been shown to be a sensitive tool for monitoring disease progression. In order to determine the clinical impact of changes seen on high-resolution computed tomography (HRCT), the relationship between the objective quantification of emphysema on HRCT, lung function and health status in 111 patients with alpha1-antitrypsin deficiency was examined (PiZ). The degree of HRCT scan abnormality correlated well (p<0.001 for all comparisons) with forced expiratory volume in one second (r = -0.60- -0.75), specific airway conductance (r = -0.67-0.76), residual volume/total lung capacity (r = 0.46-0.58) and transfer factor of the lung for carbon monoxide (r = -0.64- -0.81). In addition, the CT scans correlated (p<0.001) with health status as assessed by the St. George's Respiratory Questionnaire (SGRQ total: r = -0.38-0.50) and the Short-Form health survey (e.g. physical functioning: r = -0.39-0.54). In summary, other workers have shown high-resolution computed tomography to be a sensitive indicator of disease progression. This study confirms the relationship between high-resolution computed tomography and lung physiology, and suggests the relationship is even stronger in patients with predominantly lower zone pan-lobular emphysema than in usual chronic obstructive pulmonary disease. High-resolution computed tomography also relates to patients disability and impairment as defined by health status questionnaires and, therefore, should be considered as an alternative outcome measure particularly in alpha1-antitrypsin deficiency.

Entities:  

Mesh:

Year:  2001        PMID: 11491150     DOI: 10.1183/09031936.01.00056501

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  22 in total

1.  Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.

Authors:  Darcy D Marciniuk; P Hernandez; M Balter; J Bourbeau; K R Chapman; G T Ford; J L Lauzon; F Maltais; D E O'Donnell; D Goodridge; C Strange; A J Cave; K Curren; S Muthuri
Journal:  Can Respir J       Date:  2012 Mar-Apr       Impact factor: 2.409

2.  Emphysema lung lobe volume reduction: effects on the ipsilateral and contralateral lobes.

Authors:  Matthew S Brown; Hyun J Kim; Fereidoun G Abtin; Charlie Strange; Maya Galperin-Aizenberg; Richard Pais; Irene G Da Costa; Arash Ordookhani; Daniel Chong; Chiayi Ni; Michael F McNitt-Gray; Donald P Tashkin; Jonathan G Goldin
Journal:  Eur Radiol       Date:  2012-04-01       Impact factor: 5.315

Review 3.  Alpha1-antitrypsin deficiency. 7: Computed tomographic imaging in alpha1-antitrypsin deficiency.

Authors:  S B Shaker; T Stavngaard; J Stolk; B Stoel; A Dirksen
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

4.  Correlation between high-resolution computed tomography features and patients' characteristics in chronic obstructive pulmonary disease.

Authors:  Prem P Gupta; Rohtash Yadav; Manish Verma; Dipti Agarwal; Manoj Kumar
Journal:  Ann Thorac Med       Date:  2008-07       Impact factor: 2.219

5.  Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry.

Authors:  Robert A Stockley; David G Parr; Eeva Piitulainen; Jan Stolk; Berend C Stoel; Asger Dirksen
Journal:  Respir Res       Date:  2010-10-05

6.  Quantitative airway assessment on computed tomography in patients with alpha1-antitrypsin deficiency.

Authors:  Tsuneo Yamashiro; Shin Matsuoka; Raúl San José Estépar; Alejandro Diaz; John D Newell; Robert A Sandhaus; Patricia J Mergo; Mark L Brantly; Sadayuki Murayama; John J Reilly; Hiroto Hatabu; Edwin K Silverman; George R Washko
Journal:  COPD       Date:  2009-12       Impact factor: 2.409

7.  Can high resolution computed tomography predict lung function in patients with chronic obstructive pulmonary disease?

Authors:  K Spiropoulos; G Trakada; D Kalamboka; C Kalogeropoulou; T Petsas; G Efremidis; M Tsiamita; A Trakada; I Dimopoulos
Journal:  Lung       Date:  2003       Impact factor: 2.584

8.  Predictors of mortality in alpha1-antitrypsin deficiency.

Authors:  P A Dawkins; L J Dowson; P J Guest; R A Stockley
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

9.  Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency.

Authors:  Woo Jin Kim; Alice M Wood; Alan F Barker; Mark L Brantly; Edward J Campbell; Edward Eden; Gerard McElvaney; Stephen I Rennard; Robert A Sandhaus; James M Stocks; James K Stoller; Charlie Strange; Gerard Turino; Edwin K Silverman; Robert A Stockley; Dawn L Demeo
Journal:  Respir Res       Date:  2012-02-22

10.  Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency.

Authors:  David G Parr; Asger Dirksen; Eeva Piitulainen; Chunqin Deng; Marion Wencker; Robert A Stockley
Journal:  Respir Res       Date:  2009-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.